Allergan receives FDA Approval for use of VRAYLAR (cariprazine)
Allergan plc announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for VRAYLAR™ (cariprazine) for the maintenance…
Read More...
Read More...
